Atomoxetine |
Formulary
|
Capsules 10mg, 18mg, 25mg, 40mg, 60mg ADHD |
LSCMMG: Shared care guideline MHRA: Atomoxetine (Strattera▼): increases in blood pressure and heart rate |
|
Dexamfetamine |
Formulary
|
Tablets 5mg, 10mg, 20mg ADHD |
LSCMMG: Shared care guideline |
|
Guanfacine Intuniv® |
Formulary
|
M/R tablets 1mg, 2mg, 3mg, 4mg Specialist initiation only. |
LSCMMG: Shared care guideline |
|
Lisdexamfetamine Elvanse® |
Formulary
|
Adult Hard Capsules 30mg, 50 mg and 70mg (Elvanse Adult) Hard capsules 20mg, 30mg, 40mg, 50mg, 60mg, 70mg (Elvanse) Lisdexamfetamine (Elvanse) is recommended for use in the treatment of ADHD in children and young adults only in complex patients who meet both of the following criteria. |
LSCMMG: Shared care guideline |
|
Methylphenidate |
Formulary
|
Tablets 5mg, 10mg, 20mg All brands are formulary - choice of brand to made by specialist. Certain methylphenidate products are in limited supply and may be out of stock due to on-going supply disruption; prescribe generically to enable switching between bioequivalent MR products where possible to do so. For adult patients under the care of Psychiatry UK in South Cumbria, please prescribe as Xaggatin XL in primary care. |
LSCMMG: Shared care guideline MHRA: Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations |
|
Modafinil |
Formulary
|
Tablets 100mg |
MHRA: Modafinil (Provigil): increased risk of congenital malformations if used during pregnancy MHRA: Modafinil (Provigil): now restricted to narcolepsy |
|
Solriamfetol hydrochloride Sunosi® |
Formulary
|
Tablets 75mg, 150mg for NICE TA758: Solriamfetol for excessive daytime sleepiness caused by narcolepsy for NICE TA777: Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea |
NICE TA758: Solriamfetol for treating excessive daytime sleepiness caused by narcolepsy |
|